Global markets are more dynamic than ever – among other things, we take a look at our economic situation in 2025: challenges, opportunities and financial figures. Another highlight at Festo’s exhibition stand: Seamless Automation – with it's three dimensions of Seamless Portfolio, Seamless Connectivity, and Seamless Digital Experience we we pave the way for every industrial movement requirement of our customers. An additional highlight: At Next-Gen Life Science Automation, Festo is researching new solutions for medical technology and laboratory automation.

Here you will find the Press Kit of Hannover Messe.

Press Releases

Download all content (14.82 MB)

Festo achieved solid financial results in fiscal year 2025. Following a 3.7% decline in turnover due to economic conditions, Festo is focusing 2026 on expanding its leadership in innovation and competitiveness. To this end, the company is continuing to further develop its structure and, with an R&D ratio of over 8%, is investing in the expansion...

Read press release

04/17/2026

|

Global

Festo provides Basis for Growth

Festo achieved solid financial results in fiscal year 2025. Following a 3.7% decline in turnover due ...

Image

Festo SE & Co. KG

The development of drugs is lengthy, complex and expensive. Approaches from organ-on-a-chip research promise to shorten the time to approval of new active ingredients. Together with experts from TU Darmstadt, Festo has developed an exhibit that demonstrates the automated production of such mini-organs: A bioprinter applies human cell material to a...

Read press release

04/17/2026

|

Global

Automation of Organs-on-a-Chip for Drug ...

The development of drugs is lengthy, complex and expensive. Approaches from organ-on-a-chip research ...

Image

Festo SE & Co. KG

At Next-Gen Life Science Automation, Festo is researching new solutions for medical technology and laboratory automation. At Hannover Messe 2026, Festo and Fraunhofer IPA will be demonstrating the construction of a cassette for the process step of modifying cells in CAR-T cell therapy. Automation significantly reduces manufacturing times and...

Read press release

04/15/2026

|

Global

Personalized Cell Therapy for Cancer Treatment

At Next-Gen Life Science Automation, Festo is researching new solutions for medical technology and ...

Image

Festo SE & Co. KG

"Seamless Automation combines our broad-based solution portfolio with end-to-end connectivity and an intuitive digital experience for our customers," explains Frank Notz, Chief Sales Officer at Festo. Visitors can immerse themselves in the world of seamless automation at the Festo stand in Hall 13 at the Hannover Messe.

Read press release

03/04/2026

|

Global

Seamless automation transforms complexity into ...

"Seamless Automation combines our broad-based solution portfolio with end-to-end connectivity and an ...

Image

Festo SE & Co. KG

The Festo Virtual Assistant helps in seconds and knows the answer to almost everything. The AI-supported digital assistant for engineers and technicians provides context-related, technical answers and links directly to relevant Festo documents and engineering tools. Visitors to the Hannover Messe can discover tips and tricks with Festo experts at...

Read press release

03/04/2026

|

Global

AI power for all questions about automation ...

The Festo Virtual Assistant helps in seconds and knows the answer to almost everything. The AI ...

Image

Festo SE & Co. KG

Festo is an independent family-owned company and a global player in automation technology and technical education, with headquarters in Esslingen a.N. (Germany) – with over 20,000 employees at around 250 locations worldwide, a turnover of 3.33 billion euros and an R&D rate of over 8%. As a partner in motion, Festo offers integrated and seamless...

Read press release

04/17/2026

|

Global

The Festo Group

Festo is an independent family-owned company and a global player in automation technology and ...

Image

Festo SE & Co. KG